Renate Starr

6.5k total citations · 2 hit papers
45 papers, 3.2k citations indexed

About

Renate Starr is a scholar working on Oncology, Biomedical Engineering and Immunology. According to data from OpenAlex, Renate Starr has authored 45 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 15 papers in Biomedical Engineering and 13 papers in Immunology. Recurrent topics in Renate Starr's work include CAR-T cell therapy research (34 papers), Nanowire Synthesis and Applications (11 papers) and Immunotherapy and Immune Responses (10 papers). Renate Starr is often cited by papers focused on CAR-T cell therapy research (34 papers), Nanowire Synthesis and Applications (11 papers) and Immunotherapy and Immune Responses (10 papers). Renate Starr collaborates with scholars based in United States, Australia and China. Renate Starr's co-authors include Christine E. Brown, Stephen J. Forman, Brenda Aguilar, Michael C. Jensen, Julie R. Ostberg, Behnam Badie, Michael E. Barish, Massimo D’Apuzzo, Darya Alizadeh and Xin Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Renate Starr

45 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma

2015 592 citations Christine E. Brown, Behnam Badie et al. Clinical Cancer Research profile →
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype

2019 324 citations Darya Alizadeh, Robyn A. Wong et al. Cancer Immunology Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Renate Starr United States	19	2.5k	1.2k	991	867	629	45	3.2k
Meng-Fen Wu United States	16	2.4k 0.9×	1.0k 0.9×	627 0.6×	815 0.9×	743 1.2×	18	2.9k
Olga Dakhova United States	24	2.4k 0.9×	914 0.8×	712 0.7×	1.1k 1.3×	822 1.3×	40	3.1k
Theodoros Giavridis United States	7	3.2k 1.3×	1.4k 1.2×	1.1k 1.2×	1.6k 1.9×	1.0k 1.6×	7	4.4k
Terence J. Purdon United States	22	2.9k 1.1×	1.1k 1.0×	1.0k 1.0×	963 1.1×	837 1.3×	41	3.1k
Giedre Krenciute United States	22	1.7k 0.7×	743 0.6×	633 0.6×	957 1.1×	507 0.8×	53	2.4k
Christopher C. Kloss United States	11	2.2k 0.9×	925 0.8×	820 0.8×	932 1.1×	679 1.1×	15	2.6k
Stefanie R. Bailey United States	19	1.6k 0.6×	1.1k 0.9×	468 0.5×	699 0.8×	383 0.6×	35	2.3k
Enli Liu United States	19	4.5k 1.8×	2.1k 1.8×	1.3k 1.3×	1.8k 2.1×	1.7k 2.7×	31	5.6k
Armin Ehninger Germany	25	1.3k 0.5×	659 0.6×	553 0.6×	925 1.1×	385 0.6×	42	2.4k
Lihong Weng China	16	1.3k 0.5×	710 0.6×	479 0.5×	1.0k 1.2×	319 0.5×	50	2.4k

Countries citing papers authored by Renate Starr

Since Specialization

Citations

This map shows the geographic impact of Renate Starr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renate Starr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renate Starr more than expected).

Fields of papers citing papers by Renate Starr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renate Starr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renate Starr. The network helps show where Renate Starr may publish in the future.

Co-authorship network of co-authors of Renate Starr

This figure shows the co-authorship network connecting the top 25 collaborators of Renate Starr. A scholar is included among the top collaborators of Renate Starr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renate Starr. Renate Starr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barish, Michael E., Maryam Aftabizadeh, M. Suzette Blanchard, et al.. (2025). Chlorotoxin-directed CAR T cell therapy for recurrent glioblastoma: Interim clinical experience demonstrating feasibility and safety. Cell Reports Medicine. 6(8). 102302–102302. 2 indexed citations

Gutova, Margarita, Heini M. Natri, Vikram Adhikarla, et al.. (2024). Targeting Wnt signaling for improved glioma immunotherapy. Frontiers in Immunology. 15. 1342625–1342625. 8 indexed citations

Aftabizadeh, Maryam, Tracey Stiller, Heini M. Natri, et al.. (2023). 1525 Initial clinical experience with chlorotoxin-redirected CAR T cells for patients with recurrent glioblastoma. SHILAP Revista de lepidopterología. A1750–A1750. 1 indexed citations

Barish, Michael E., Lihong Weng, Yubo Zhai, et al.. (2022). Spatial organization of heterogeneous immunotherapy target antigen expression in high-grade glioma. Neoplasia. 30. 100801–100801. 11 indexed citations

Kuo, Cheng-Fu, Kurt J. Jenkins, Wen-Chung Chang, et al.. (2022). Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells. Journal for ImmunoTherapy of Cancer. 10(6). e003752–e003752. 7 indexed citations

Stern, Lawrence A., Sharareh Gholamin, Ignacio Moraga, et al.. (2022). Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy. Proceedings of the National Academy of Sciences. 119(33). e2112006119–e2112006119. 18 indexed citations

Alizadeh, Darya, Robyn A. Wong, Sharareh Gholamin, et al.. (2021). IFNγ Is Critical for CAR T Cell–Mediated Myeloid Activation and Induction of Endogenous Immunity. Cancer Discovery. 11(9). 2248–2265. 103 indexed citations

Wang, Dongrui, Briana C. Prager, Ryan C. Gimple, et al.. (2020). CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies. Cancer Discovery. 11(5). 1192–1211. 121 indexed citations

Alizadeh, Darya, Robyn A. Wong, Xin Yang, et al.. (2019). IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype. Cancer Immunology Research. 7(5). 759–772. 324 indexed citations breakdown →

10.

Wang, Dongrui, Renate Starr, Darya Alizadeh, et al.. (2019). In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function. Journal of Visualized Experiments. 16 indexed citations

11.

Wang, Dongrui, Brenda Aguilar, Renate Starr, et al.. (2018). Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activity. JCI Insight. 3(10). 162 indexed citations

12.

Weist, Michael R., Renate Starr, Brenda Aguilar, et al.. (2018). PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with ⁸⁹Zr-Oxine. Journal of Nuclear Medicine. 59(10). 1531–1537. 105 indexed citations

13.

Brown, Christine E., Brenda Aguilar, Renate Starr, et al.. (2017). Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. Molecular Therapy. 26(1). 31–44. 226 indexed citations

14.

Brown, Christine E., Behnam Badie, Michael E. Barish, et al.. (2015). Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma. Clinical Cancer Research. 21(18). 4062–4072. 592 indexed citations breakdown →

15.

Jonnalagadda, Mahesh, Armen Mardiros, Ryan Urak, et al.. (2014). Chimeric Antigen Receptors With Mutated IgG4 Fc Spacer Avoid Fc Receptor Binding and Improve T Cell Persistence and Antitumor Efficacy. Molecular Therapy. 23(4). 757–768. 144 indexed citations

16.

Yang, Fan, Sangkil Nam, Christine E. Brown, et al.. (2014). A Novel Berbamine Derivative Inhibits Cell Viability and Induces Apoptosis in Cancer Stem-Like Cells of Human Glioblastoma, via Up-Regulation of miRNA-4284 and JNK/AP-1 Signaling. PLoS ONE. 9(4). e94443–e94443. 62 indexed citations

17.

Mahadev, Vaidehi, Renate Starr, Sarah Wright, et al.. (2014). Cytokine Induction of VCAM-1 but Not IL13Rα2 on Glioma Cells: A Tale of Two Antibodies. PLoS ONE. 9(5). e95123–e95123. 1 indexed citations

18.

Brown, Christine E., Renate Starr, Brenda Aguilar, et al.. (2012). Stem-like Tumor-Initiating Cells Isolated from IL13Rα2 Expressing Gliomas Are Targeted and Killed by IL13-Zetakine–Redirected T Cells. Clinical Cancer Research. 18(8). 2199–2209. 185 indexed citations

19.

Brown, Christine E., Renate Starr, Catalina Martínez, et al.. (2009). Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells. Cancer Research. 69(23). 8886–8893. 113 indexed citations

20.

Brown, Christine E., Brenda Aguilar, Renate Starr, et al.. (2007). Tumor-Derived Chemokine MCP-1/CCL2 Is Sufficient for Mediating Tumor Tropism of Adoptively Transferred T Cells. The Journal of Immunology. 179(5). 3332–3341. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact